acute myeloïde leukemie en myelodysplastische syndromen gerelateerd aan topo-isomerase type 2-inhibitor
A subgroup of therapy-related myeloid neoplasms (t-MN), associated with treatment of an unrelated neoplastic disease with cytotoxic agents, like etoposide, doxorubicin, daunorubicin and others. The neoplastic cells often show rearrangements involving